Tag Archives: personalised cancer therapies

The Institute of Cancer Research reveals new combination therapy using reovirus and cancer drugs to supercharge immune attack against tumours

(IN BRIEF) The Institute of Cancer Research, London, has published two major studies demonstrating how pairing a cancer-killing reovirus with targeted therapies such as talazoparib and palbociclib can greatly strengthen immune activity and tumour destruction. By disrupting cancer cell defences … Read the full press release